Feline Pemphigus Foliaceus: Part 2: Diagnosis and Current Treatments.

The diagnosis of feline pemphigus foliaceus relies on a comprehensive approach combining clinical evaluation, cytology, and histopathology. Clinical examination looks for pustules, erosions, and crusts, typically distributed symmetrically on the face and paws. Cytology, via Tzanck preparation, reveals characteristic neutrophils and acantholytic keratinocytes. Histopathology, the cornerstone of diagnosis, shows intraepidermal pustules containing neutrophils and acantholytic cells.

Diagnosis

The diagnosis of feline pemphigus foliaceus relies on a multifaceted approach, combining clinical evaluation, cytological analysis, and histopathological examination. This comprehensive approach is essential for establishing an accurate diagnosis and differentiating PF from other skin conditions that may present similar clinical signs.

The first diagnostic criterion is clinical observation. Veterinarians should be attentive to the presence of pustules, which are the characteristic primary lesions of PF. However, as mentioned earlier, these pustules are often transient and can rapidly evolve into superficial erosions and crusts. The distribution of lesions is also a key element of the clinical evaluation. Predominant involvement of the face and paws, with a bilaterally symmetrical distribution, is highly suggestive of feline PF.

The second major diagnostic criterion is histopathological examination. This examination reveals the presence of superficial epidermal or follicular pustules containing neutrophils and acantholytic keratinocytes. These are the histological hallmark of PF and their identification is crucial for a definitive diagnosis.

The third equally important criterion is the exclusion of other acantholytic neutrophilic pustular disorders. In particular, staphylococcal pyoderma associated with exfoliation and pustular dermatophytosis must be ruled out, as they can present clinical and histological characteristics similar to PF.

Cytology

Cytology plays a crucial role in the initial diagnostic process of feline PF. The technique of choice is the Tzanck preparation, which allows for rapid and relatively non-invasive evaluation of skin lesions. To perform this preparation, the veterinarian carefully selects an intact pustule. With caution, they rupture the pustule with a small gauge needle, then gently spread its contents onto a microscope slide.

Microscopic examination of a sample from a cat with PF typically reveals a characteristic image. Numerous non-degenerate neutrophils are observed, indicating a sterile inflammatory process rather than a bacterial infection. However, the most distinctive and diagnostic element is the presence of acantholytic keratinocytes. These cells are immature keratinocytes that have lost their normal adhesion to surrounding cells. They are distinguished by their rounded shape and large size, generally four times or more the size of a neutrophil.

Acantholytic keratinocytes exhibit specific cytological characteristics. Their cytoplasm is often abundant and intensely stained, reflecting their origin in the deeper layers of the epidermis. The nucleus of these cells is generally intact and may vary in size, but it usually remains well-defined. The presence of these cells in significant numbers, associated with neutrophilic inflammation, is highly suggestive of feline PF.

It is important to note that the quality and representativeness of the cytological sample largely depend on the sampling technique. An intact pustule will generally provide the most informative sample. However, in many cases, pustules may be rare or already ruptured at the time of examination. In these situations, the veterinarian may attempt to collect material from under recent crusts, though these samples may be less rich in diagnostic cells.

Histopathology

Histopathology remains the cornerstone of definitive diagnosis of feline PF. It not only confirms the diagnosis but also helps exclude other skin conditions that may present similar clinical characteristics. To obtain the best results, it is crucial to carefully select the lesions to be biopsied. Ideally, biopsies should be taken from intact pustules or recent lesions, as these are most likely to show the typical histological features of PF.

Histopathological examination of a feline PF sample reveals several distinctive characteristics:

Firstly, the epidermis generally shows hyperplasia, which can range from mild to severe. This hyperplasia is primarily due to acanthosis, i.e., a thickening of the spinous layer of the epidermis. This epidermal reaction reflects the skin’s response to chronic inflammation and the continuous loss of keratinocytes due to the acantholytic process.

Secondly, hyperkeratosis is frequently observed, which is mainly of the orthokeratotic type. This means that the stratum corneum of the epidermis is thickened, but the cells retain their nuclei. In some cases, focal areas of parakeratosis may also be observed, where the cells of the stratum corneum abnormally retain their nuclei.

The underlying dermis generally shows an inflammatory infiltrate, which can range from mild to severe. This infiltrate is typically described as perivascular to interstitial, meaning it concentrates around blood vessels but can also extend into the surrounding connective tissue.

The most diagnostic histological feature of PF is the presence of intra-epidermal pustules. These pustules primarily contain neutrophils, although eosinophils may also be present in some cases. Within these pustules, acantholytic cells are observed, which are the histological hallmark of PF. These acantholytic cells are often grouped in “rafts,” forming characteristic clusters within the pustule.

An interesting point to note is the frequent presence of mast cells in histological samples of feline PF. In a large retrospective study, 94% of samples showed mast cells, and in 20% of cases, they were even the predominant cell type. This observation raises interesting questions about the potential role of mast cells in the pathogenesis of feline PF, though their exact significance remains to be elucidated.

It is important to emphasize that the interpretation of histopathological results must always be performed in conjunction with clinical observations and the results of other diagnostic tests. In some cases, particularly when lesions are chronic or have been altered by previous treatments, histological features may be less obvious or atypical. In these situations, repeated biopsies or the use of complementary techniques, such as direct immunofluorescence, may be necessary to confirm the diagnosis.

SI VOUS ETES VETERINAIRE : Pour lire la suite de cet article, veuillez vous enregistrer en haut à droite. Merci

Prognosis and follow-up

The prognosis for feline pemphigus foliaceus is generally favorable with appropriate treatment, but it is important to note that the disease often requires long-term, and in some cases, lifelong treatment. The response to treatment can vary considerably from individual to individual, and careful management is necessary to optimize therapeutic outcomes while minimizing potential side effects.

The decision to gradually reduce medication once remission is achieved is often delicate and requires close collaboration between the veterinarian and the owner. This gradual reduction phase is crucial because it aims to find the minimal effective dose that maintains remission while reducing the risk of long-term side effects.

It is crucial to emphasize that this protocol is only a general guide and must be adapted to each individual patient. Some cats may require slower reductions or higher maintenance doses, while others may tolerate faster reductions. The key to success lies in close monitoring and regular communication between the veterinarian and the owner.

Regular follow-up is an essential aspect of long-term management of feline PF. These check-ups allow for evaluation of treatment response, early detection of any relapse, and monitoring for the appearance of potential side effects. During these visits, the veterinarian will generally perform a complete physical examination, paying particular attention to the condition of the skin and coat. Additional examinations, such as blood tests, may be recommended periodically to monitor the systemic effects of immunosuppressive treatment.

It is also important to educate owners about the signs of relapse to watch for. These may include the reappearance of crusts, erosions, or areas of alopecia, as well as signs of increased pruritus. Early detection of relapses can allow for quick intervention and avoid the need to return to high doses of medication.

Managing potential side effects is another crucial aspect of long-term follow-up. Owners should be informed of the possible side effects of the medications used and encouraged to report any notable changes in their cat’s behavior or health. For cats on long-term corticosteroids, regular blood glucose monitoring may be recommended to detect early development of steroid-induced diabetes mellitus.

In some cases, complementary therapies may be considered to support the main treatment and improve the patient’s quality of life. For example, gentle topical care can help relieve discomfort and promote healing of skin lesions. Nutritional supplements, such as omega-3 fatty acids, may be beneficial in supporting skin and coat health.

It is important to note that even with optimal treatment, some cats may experience periods of relapse. These episodes should not be considered therapeutic failures, but rather challenges to be addressed within the framework of long-term disease management. In these situations, a re-evaluation of the treatment plan may be necessary, which may involve a temporary increase in medication doses or the addition of supplementary therapeutic agents.

The duration of treatment can vary considerably from patient to patient. Some cats may require lifelong treatment, while others may eventually be completely weaned off their medication. The decision to stop treatment must be made with great caution and only after a prolonged period of stable remission.

Conclusion

Feline pemphigus foliaceus represents a significant challenge in veterinary dermatology, requiring a rigorous diagnostic approach and careful therapeutic management. A thorough understanding of its pathogenesis, clinical manifestations, and available treatment options is crucial for providing the best possible care to affected cats.

The evolution of knowledge about feline corticosteroid metabolism and the introduction of new therapeutic agents like cyclosporine have significantly improved our ability to effectively manage this disease. However, each case of feline PF remains unique and requires an individualized approach, taking into account the particularities of each patient and their owner’s preferences.

Early and accurate diagnosis, followed by appropriate treatment, can allow many cats with PF to enjoy a good quality of life in the long term. The key to success lies in close collaboration between the veterinarian and the owner, with regular follow-up and continuous adaptation of the treatment plan based on the patient’s response.

Although significant progress has been made in understanding and treating feline PF, many questions remain unanswered. Further research is needed to fully elucidate the underlying mechanisms of the disease, identify new potential therapeutic targets, and develop even more effective and better tolerated treatment strategies.

Ultimately, successful management of feline pemphigus foliaceus relies on a holistic approach, combining optimized medical therapy, careful monitoring, and appropriate supportive care. With proper management, many cats with PF can lead comfortable and fulfilling lives, testament to the remarkable progress made in this area of veterinary medicine.

Bibliography

Anderson, JG; Bizikova, P; Linder, KE | Erosive and ulcerative stomatitis in dogs and cats: which immune-mediated diseases to consider? | J Am Vet Med Assoc. 2023 Apr 17;261(S1):S48-S57. doi: 10.2460/javma.22.12.0573. PMID: 37059419

Barrs, VR; Beatty, JA; Hobi, S; Sandy, JR | Successful management of feline pemphigus foliaceus with pentoxifylline and topical hydrocortisone aceponate. | Vet Med Sci. 2022 May;8(3):937-944. doi: 10.1002/vms3.768. PMID: 35212177

Bizikova, P; Burrows, A | Feline pemphigus foliaceus: original case series and a comprehensive literature review. | BMC Vet Res. 2019 Jan 9;15(1):22. doi: 10.1186/s12917-018-1739-y. PMID: 30626385

Bizikova, P; Levy, BJ; Mamo, LB | Detection of circulating anti-keratinocyte autoantibodies in feline pemphigus foliaceus. | Vet Dermatol. 2020 Oct;31(5):378-e100. doi: 10.1111/vde.12861. PMID: 32372490

Bizikova, P; Mendoza-Kuznetsova, E; Piedra-Mora, C | Comorbidity of ectopic thymoma-associated exfoliative dermatitis and pemphigus foliaceus in a cat. | Can Vet J. 2021 Oct;62(10):1067-1070. PMID: 34602633

Izydorczyk, V; Pye, C | Pemphigus foliaceus in cats. | Can Vet J. 2024 Mar;65(3):297-300. PMID: 38434171

Jordan, TJM; Affolter, VK; Outerbridge, CA; Goodale, EC; White, SD | Clinicopathological findings and clinical outcomes in 49 cases of feline pemphigus foliaceus examined in Northern California, USA (1987-2017). | Vet Dermatol. 2019 Jun;30(3):209-e65. doi: 10.1111/vde.12731. PMID: 30779233

Linder, KE; Olivry, T; Tham, HL | Deep pemphigus (pemphigus vulgaris, pemphigus vegetans and paraneoplastic pemphigus) in dogs, cats and horses: a comprehensive review. | BMC Vet Res. 2020 Nov 23;16(1):457. doi: 10.1186/s12917-020-02677-w. PMID: 33228633